Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099254 · ClinicalTrials.gov registry record
Internal Jugular Vein Cross Sectional Area
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 38
- Enrollment target
NCT01099254: Completed study, sponsored by University of Iowa.
NCT01099254 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099254 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The Trendelenburg position is used to distend the central veins, improving both success and safety of vascular cannulation. The purpose of this study is to measure the cross-sectional area of the internal jugular vein (IJV) in three different positions, using surface ultrasound.
Primary Outcome
There will be substantial anatomic variation in venous size. Further, Trendelenburg positioning will have little impact on venous cross-sectional area in most subjects when compared with supine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-03 |
What the finished NCT01099254 record still lists
NCT01099254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01099254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01099254 about?
NCT01099254 is a clinical study titled "Internal Jugular Vein Cross Sectional Area". The Trendelenburg position is used to distend the central veins, improving both success and safety of vascular cannulation. The purpose of this study is to measure the cross-sectional area of the internal jugular vein (IJV) in three different positions, using surface ultrasound.
What is the current status of trial NCT01099254?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2007-08. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT01099254?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia